| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0003 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0003 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0004 |